This exercise revealed downregulated GATA2 and SESN3 in MKX-high MM patients (S6 Fig), showing target genes similar to those identified in AML, although inhibition of SESN3 contrasts with its activation by MKX in OCI-AML3. This evidence concerns the gene GATA2 and acute myeloid leukemia.